Donoghue Forlines LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Donoghue Forlines LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2022$721,000
+58.5%
8,708
+43.6%
0.16%
+102.6%
Q4 2021$455,000
-26.1%
6,065
+14.4%
0.08%
-35.3%
Q3 2021$616,000
-33.6%
5,301
+26.7%
0.12%
-31.2%
Q2 2021$928,000
+55.2%
4,183
-7.5%
0.17%
+49.1%
Q1 2021$598,000
-18.6%
4,522
+6.5%
0.12%
-18.3%
Q4 2020$735,000
-68.1%
4,247
-86.2%
0.14%
-56.7%
Q3 2019$2,307,00030,8560.33%
Other shareholders
NOVOCURE LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$77,833,00015.51%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Darsana Capital Partners LP 700,000$155,274,0004.42%
MORGAN JESS S & CO INC 23,775$5,274,0003.47%
Soleus Capital Management, L.P. 98,975$21,955,0003.38%
Montanaro Asset Management Ltd 116,650$25,875,0003.26%
Taylor Frigon Capital Management LLC 31,035$6,884,0002.15%
Rhenman & Partners Asset Management AB 120,000$26,618,0001.81%
COURAGE CAPITAL MANAGEMENT LLC 10,000$2,218,0001.33%
Derbend Asset Management 5,789$1,284,0001.20%
View complete list of NOVOCURE LTD shareholders